By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Simvastatin

Simvastatin

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
5 Min Read
SHARE
3 min read|612 words

What is Simvastatin?

Simvastatin is a prescription medication that belongs to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease in patients with elevated blood cholesterol. Simvastatin is one of the most widely prescribed cholesterol-lowering medications worldwide.

Uses

Simvastatin is approved for several cardiovascular-related conditions:

  • High cholesterol (hypercholesterolemia): Reduces elevated total cholesterol, LDL (“bad”) cholesterol, and triglycerides while modestly increasing HDL (“good”) cholesterol
  • Primary prevention of cardiovascular disease: Reduces the risk of heart attack and stroke in patients with multiple risk factors but no existing heart disease
  • Secondary prevention after cardiovascular events: Prevents future heart attacks, strokes, and other cardiovascular events in patients with existing coronary heart disease
  • Familial hypercholesterolemia: Treats inherited conditions causing extremely high cholesterol levels
  • Diabetic dyslipidemia: Manages abnormal cholesterol levels commonly seen in patients with type 2 diabetes

How it works

Simvastatin works by blocking an enzyme called HMG-CoA reductase, which plays a crucial role in cholesterol production in the liver. By inhibiting this enzyme, the medication reduces the liver’s ability to manufacture cholesterol, forcing the body to remove cholesterol from the bloodstream to meet its needs. This mechanism effectively lowers blood cholesterol levels and reduces the buildup of cholesterol plaques in arteries.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Headache
  • Muscle aches or weakness
  • Nausea
  • Stomach pain or upset
  • Constipation
  • Upper respiratory tract infections
  • Dizziness
  • Elevated liver enzymes

Serious side effects requiring immediate medical attention:

  • Severe muscle pain, tenderness, or weakness (potential rhabdomyolysis)
  • Dark-colored urine or decreased urination
  • Yellowing of skin or eyes (jaundice)
  • Severe abdominal pain
  • Unexplained fatigue or weakness

Warnings and precautions

  • Liver disease: Patients with active liver disease or unexplained elevated liver enzymes should not use simvastatin. Regular liver function monitoring may be required during treatment.
  • Pregnancy and breastfeeding: Simvastatin is contraindicated during pregnancy and breastfeeding as it may harm fetal development. Women of childbearing age should use effective contraception.
  • Muscle disorders: Patients with a history of muscle disorders or those at increased risk for muscle problems should be closely monitored, especially when starting treatment or increasing doses.
  • Age considerations: Elderly patients may be at higher risk for muscle-related side effects and may require dose adjustments.
  • Kidney impairment: Patients with severe kidney disease may need dose modifications or closer monitoring due to increased risk of muscle complications.

Interactions

  • Cyclosporine: Significantly increases simvastatin levels, greatly raising the risk of muscle damage
  • Gemfibrozil and other fibrates: Increases risk of muscle toxicity when combined with statins
  • Warfarin: May enhance anticoagulant effects, requiring more frequent INR monitoring
  • Grapefruit juice: Contains compounds that can increase simvastatin blood levels, potentially causing side effects
  • Certain antibiotics (clarithromycin, erythromycin): Can increase simvastatin concentrations and toxicity risk
  • Antifungal medications (itraconazole, ketoconazole): Inhibit simvastatin metabolism, increasing drug levels
  • HIV protease inhibitors: Significantly increase simvastatin exposure, contraindicated in most cases
  • Niacin (high doses): May increase risk of muscle problems when combined with simvastatin

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages range from 5 mg to 40 mg once daily, usually taken in the evening. The starting dose is commonly 10-20 mg daily, with adjustments made based on cholesterol response and tolerability. The maximum recommended dose is 40 mg daily, as higher doses significantly increase the risk of muscle complications. Patients taking certain interacting medications may require lower maximum doses. Dosage should always be individualized and determined by a healthcare provider based on the patient’s specific condition, response to treatment, and risk factors.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Simvastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/simvastatin/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Simvastatin

By
GMJ News Desk
01/06/2026

Fluvastatin

By
GMJ News Desk
01/06/2026

Lovastatin

By
GMJ News Desk
01/06/2026

Pravastatin

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up